top of page

Houston Oncology Summit: MD Anderson’s Funda Meric-Bernstam on antibody-drug conjugates

She describes how antibody-drug conjugates have improved over recent years and lists some of her favorite targets and indications that ADCs are going after.

Brought to you by:


Join the BiotechTV mailing list

Thanks for subscribing!

bottom of page